Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The purine synthesis pathway consists of a series of enzymatic reactions that build the purine ring system, ultimately producing inosine monophosphate (IMP), which serves as the precursor for adenosine monophosphate (AMP) and guanosine monophosphate (GMP). This pathway is essential for nucleotide biosynthesis in all cells. Key enzymes include Glutamine PRPP amidotransferase (GPAT/PurF), GAR synthetase, GAR transformylase, FGAM synthetase, AIR synthetase, PAICS, and ATIC. It is regulated by feedback inhibition of IMP/AMP/GMP and activated by PRPP. Inhibitors are used as immunosuppressants and cancer therapeutics.
Inhibition of purine nucleotide synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine Synthesis Pathway Enzymes.